Renal transplant recipient attitudes toward steroid use and steroid withdrawal

Clinical Transplantation

Volumn 17, Issue 2, 2003, Pages 135-139

  Prasad Ramesh, G V ^a   Nash, Michelle N ^a   McFarlane, Philip A ^a   Zaltzman, Jeffrey S ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Prednisone; Questionnaire; Renal transplantation; Steroid avoidance; Steroid withrawal; Steroids; Survey

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS;

ADULT; AGE; ARTHROPATHY; ARTICLE; ASIAN; BLOOD DISEASE; BODY FAT; BODY WEIGHT DISORDER; BONE DISEASE; CADAVER KIDNEY; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG CHOICE; DRUG EFFICACY; DRUG WITHDRAWAL; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HAIR DISEASE; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEGRO; PATIENT ATTITUDE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RACE DIFFERENCE; RECIPIENT; RISK; SKIN DISEASE; STEROID THERAPY; WEIGHT GAIN;

AFRICAN AMERICANS; CHOICE BEHAVIOR; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREDNISONE; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS;

EID: 0037964803     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00034.x     Document Type: Article

References (23)

1. Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Transplantation 1999: 68: 1865.
2. Morris PJ, Chan L, French ME, Ting A. Low dose oral prednisolone in renal transplantation. Lancet 1982: 8271: 525.
3. Schulak JA, Mayes JT, Moritz CE, Hricik DE. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant recipients. Transplantation 1990: 49: 327.
4. Kupin W, Venkat KK, Oh HK, Dienst S. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Transplantation 1988: 45: 53.
5. Reisman L, Lieberman KV, Burrows L, Schnazer H. Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone. Transplantation 1990: 49: 76.
6. Hricik DE, Mayes JT, Schulak JA. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 1991: 18: 353.
7. Hariharan S, Schroeder TJ, Weiskittel P, Alexander JW, First MR. Prednisone withdrawal in HLA identical one haplotype-matched live-related and cadaver renal transplant recipients. Kidney Int 1993: 43 (Suppl.): S30.
8. Hricik DE, O'toole M, Schulak JA, Herson J. Steroid-free, cyclosporine-based immunosuppression after renal transplantation: a meta analysis of controlled trials. J Am Soc Nephrol 1993: 4: 1300.
9. Sivaraman P, Nussbaumer G, Landsberg D. Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 2001: 37: 1162.
10. Cole E, Landsberg D, Russell D et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001: 72: 845.
11. Moons P, De Geest S, Abraham I, Van Cleemput J, Vanhaecke J. Symptom experience associated with maintenance immunosuppression after heart transplantantion: patients' appraisal of side effects. Heart Lung 1998: 27: 315.
12. De Geest S, Moons P. The patient's appraisal of side-effects: the blind spot in quality-of-life assessments in transplant recipients. Nephrol Dial Transplant 2000: 15: 457.
13. Likert RA. A technique for the development of attitude scales. Educational Psychol Measurement 1952: 12: 313.
14. Siegal BR, Hanson P, Viswanathan R, Margolis R, Butt KMH. Renal transplant patients' health beliefs. Transplant Proc 1989: 21: 3977.
15. Hricik De. Steroid-free immunosuppression in kidney transplantation: an editorial review. Am J Transplant 2002: 2: 19.
16. Lowe M, Kerridge IH, Mitchell KR. 'These sorts of people don't do very well': race and allocation of health care resources. J Med Ethics 1995: 21: 356.
17. Manificat S, Dazord A, Cochat P, Nicolas J. Evaluation of the quality of life in pediatrics: how to collect the point of view of children. Arch Pediatr 1997: 4: 1238.
18. Greenstein SM, Siegal B. Ethnic and gender variations in postrenal transplant physical symptoms. Transplant Proc 1997: 29: 3743.
19. Johnson CD, Wicks MN, Milstead J, Hartwig M, Hathaway DK. Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Sch 1998: 30: 125.
20. Fryer JP, Granger DK, Leventhal JR, Gillingham K, Najarian JS, Matas AJ. Steroid-related complications in the cyclosporine era. Clin Transplant 1994: 8: 224.
21. Winsett RP, Stratta RJ, Alloway R, Wicks MN, Hathaway DK. Immunosuppressant side effect profile does not differ between organ transplant types. Clin Transplant 2001: 15 (Suppl. 6): 46.
22. Hilbrands LB, Hoitsma AJ, Koene RAP. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 1995: 59: 1263.
23. Hathaway DK, Winsett RP, Milstead J, Wicks MN, Gaber AO. Quality of life outcomes associated with variable posttransplant prednisone dosing regimens. J Transpl Coord 1996: 6: 64.